Atıf İçin Kopyala
Cengiz M., Yilmaz G., ÖZENİRLER MAYER S.
CLINICAL LABORATORY, cilt.67, sa.3, ss.804-820, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
67
Sayı:
3
-
Basım Tarihi:
2021
-
Doi Numarası:
10.7754/clin.lab.2020.200709
-
Dergi Adı:
CLINICAL LABORATORY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.804-820
-
Anahtar Kelimeler:
biglycan, liver fibrosis, NAFLD, NASH, non-invasive marker, MEAN PLATELET VOLUME, IDIOPATHIC THROMBOCYTOPENIC PURPURA, SIZE DEVIATION WIDTH, PREDICTORS, CHILDREN
-
Gazi Üniversitesi Adresli:
Evet
Özet
Background: Non-alcoholic steatohepatitis (NASH) has risen in prevalence substantially through the years. Although course and progression of the disease are variable, fibrosis is the most important factor. We intended to explore utility of serum biglycan (BGN) in NASH and its capacity in anticipating liver fibrosis.